FGFR3 and head and neck cancer: More importantly, preclinical studies have demonstrated that FGFR inhibition reduced cell proliferation and increased cell apoptosis in head and neck cancer in vitro and in vivo[62], highlighting the potential prognostic and therapeutic role of FGFR3 in HNSCC.